XML 90 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Comprehensive (Loss) Income
Stockholders' equity beginning balance (in shares) at Dec. 31, 2016   38,251,826      
Stockholders' equity beginning balance at Dec. 31, 2016 $ 225,597 $ 39 $ 590,474 $ (364,491) $ (425)
AOCI Attributable to Parent, Net of Tax [Roll Forward]          
Stock-based compensation 28,248   28,248    
Issuance of common stock (in shares)   6,216,216      
Issuance of common stock 215,802 $ 6 215,796    
Exercise of stock options (in shares)   474,056      
Exercise of stock options 3,893 $ 1 3,892    
Vesting of restricted stock units, net of shares withheld for taxes (in shares)   282,158      
Vesting of restricted stock units, net of shares withheld for taxes (226)   (226)    
Issuance of common stock related to ESPP (in shares)   33,698      
Issuance of common stock related to ESPP 827   827    
Net exercise of warrants to purchase common stock (in shares)   3,221      
Net exercise of warrants to purchase common stock 0        
Unrealized gain/loss on available-for-sale securities, net of tax (470)       (470)
Net loss (108,454)     (108,454)  
Stockholders' equity ending balance (in shares) at Dec. 31, 2017   45,261,175      
Stockholders' equity ending balance at Dec. 31, 2017 365,217 $ 46 839,090 (473,024) (895)
AOCI Attributable to Parent, Net of Tax [Roll Forward]          
Stock-based compensation 24,569   24,569    
Exercise of stock options (in shares)   779,711      
Exercise of stock options 15,931 $ 1 15,930    
Vesting of restricted stock units, net of shares withheld for taxes (in shares)   170,516      
Vesting of restricted stock units, net of shares withheld for taxes (731)   (731)    
Issuance of common stock related to ESPP (in shares)   30,896      
Issuance of common stock related to ESPP 1,085   1,085    
Net exercise of warrants to purchase common stock (in shares)   18,449      
Net exercise of warrants to purchase common stock 797   797    
Unrealized gain/loss on available-for-sale securities, net of tax 335       335
Net loss (118,871)     (118,871)  
Stockholders' equity ending balance (in shares) at Dec. 31, 2018   46,260,747      
Stockholders' equity ending balance at Dec. 31, 2018 292,037 $ 47 879,099 (586,549) (560)
AOCI Attributable to Parent, Net of Tax [Roll Forward]          
Stock-based compensation 22,995   22,995    
Issuance of common stock (in shares)   6,151,163      
Issuance of common stock $ 248,130 $ 6 248,124    
Exercise of stock options (in shares) 344,000 344,257      
Exercise of stock options $ 10,096   10,096    
Vesting of restricted stock units, net of shares withheld for taxes (in shares)   334,141      
Vesting of restricted stock units, net of shares withheld for taxes (802)   (802)    
Issuance of common stock related to ESPP (in shares)   33,259      
Issuance of common stock related to ESPP 1,295   1,295    
Unrealized gain/loss on available-for-sale securities, net of tax 583       583
Net loss (124,858)     (124,858)  
Stockholders' equity ending balance (in shares) at Dec. 31, 2019   53,123,567      
Stockholders' equity ending balance at Dec. 31, 2019 $ 449,476 $ 53 $ 1,160,807 $ (711,407) $ 23